The latest twist in the battle to control CRISPR

Credit: Cal Alumni Association

Emmanuelle Charpentier and Jennifer Doudna won the Nobel Prize but not the intellectual property dispute and are now ready to give up two patents granted in Europe. The scoop once again comes from Antonio Regalado, who gained fame a few years ago for breaking the CRISPR babies scandal.

Continue reading

Salomon’s patent dilemma and the first CRISPR therapy

In the story from the Bible King Solomon ruled between two women who both claimed to be the mother of a child. In the CRISPR saga the contention is between biotech companies over foundational patents, and the next crucial episode will unveil the consequences for the first CRISPR therapy, Casgevy.

Continue reading

A move (and a call) to make plant editing more accessible

The Dutch town of Wageningen was already a spot on the genome-editing map for the work of the CRISPR pioneer John van der Oost. Its university now aims to inspire a worldwide change in CRISPR patents policies, by announcing that it will allow non-profit organizations to use its CRISPR technology for free for non-commercial agricultural applications.

Continue reading